Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic.
Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic.
复制标题
DOI：
10.1002/acr2.11340
复制
发表时间：
2021-12
影响因子：
3.4
通讯作者：
Wallace ZS
中科院分区：
文献类型：
--
作者：
Cook C;Cox H;Fu X;Zhang Y;Stone JH;Choi HK;Wallace ZS
调查2019冠状病毒病（COVID-19）感染的感知风险和结局，以及COVID-19大流行期间类风湿关节炎（RA）患者的防护措施。我们调查了2020年7月16日至11月8日期间大型医疗保健系统中的RA参与者。参与者报告了RA治疗、COVID-19风险认知和防护措施（如口罩、社交距离和隔离）。我们研究了人口统计学和疾病特异性因素与风险感知的关联，以及风险感知与防护措施的关联。在494名参与者中，分别有195名（40%）、169名（34%）和130名（26%）强烈同意、同意或不确定/不同意他们的RA使他们面临更高的COVID-19风险或不良结局。年轻（比值比[OR]：0.98）、合并症（OR：1.60）和生物疾病缓解抗风湿药物（bDMARD）使用（OR：1.75）与较高的感知风险独立相关。在那些强烈同意、同意或不确定/不同意他们有更大风险的人中，分别有165（85%）、118（70%）和69（53%）人采取了所有三种屏蔽措施（P < 0.0001）。那些强烈同意或同意他们处于更高风险的人更有可能使用所有三种屏蔽措施（OR：4.16和1.97，分别）。使用bDMARD和糖皮质激素与使用所有三种保护措施相关（OR：分别为1.99和1.81）。RA患者对COVID-19风险的认知差异很大。与感知风险相关的因素与观察性研究中发现的与不良结局相关的因素不同。更大的感知风险与更严格的屏蔽相关，这对患者教育和心理健康有影响。
To investigate the perceived risk of coronavirus disease 2019 (COVID‐19) infection and outcomes as well as shielding practices among patients with rheumatoid arthritis (RA) during the COVID‐19 pandemic. We surveyed participants with RA in a large health care system between July 16 and November 8, 2020. Participants reported RA treatment, COVID‐19 risk perception, and shielding practices (eg, masks, social distancing, and quarantining). We examined the association of demographic and disease‐specific factors with risk perception and the association of risk perception with shielding practices. Of 494 participants, 195 (40%), 169 (34%), and 130 (26%) strongly agreed, agreed, or were uncertain/disagreed that their RA put them at higher risk for COVID‐19 or poor outcomes, respectively. Younger age (odds ratio [OR]: 0.98), having a comorbidity (OR: 1.60), and biologic disease‐modifying antirheumatic drug (bDMARD) use (OR: 1.75) were independently associated with a higher perceived risk. Among those who strongly agreed, agreed, or were uncertain/disagreed that they had greater risk, 165 (85%), 118 (70%), and 69 (53%), respectively, practiced all three shielding measures (P < 0.0001). Those who strongly agreed or agreed that they were at higher risk were more likely to use all three shielding practices (OR: 4.16 and 1.97, respectively). bDMARD use and glucocorticoid use were associated with using all three shielding measures (OR: 1.99 and 1.81, respectively). Perception of COVID‐19 risk among patients with RA varies substantially. Factors associated with perceived risk are different from those found to be associated with worse outcomes in observational studies. Greater perceived risk is associated with more strict shielding, which has implications for patient education and mental health.
登录
查看更多内容
影响因子：
6.2
作者：
Glintborg B;Jensen DV;Engel S;Terslev L;Pfeiffer Jensen M;Hendricks O;Ostergaard M;Horskjær Rasmussen S;Adelsten T;Colic A;Danebod K;Kildemand M;Loft AG;Munk HL;Pedersen JK;Østgård RD;Møller Sørensen C;Krogh NS;Agerbo J;Ziegler C;Hetland M
通讯作者：
Hetland M
影响因子：
13.3
作者：
Mikuls, Ted R.;Johnson, Sindhu R.;Saag, Kenneth G.
通讯作者：
Saag, Kenneth G.
影响因子：
3.9
作者：
Ma, Margaret H. Y.;Tay, Sen Hee;Lahiri, Manjari
通讯作者：
Lahiri, Manjari
影响因子：
4
作者：
Cleaton N;Raizada S;Barkham N;Venkatachalam S;Sheeran TP;Adizie T;Sapkota H;Singh BM;Bateman J
通讯作者：
Bateman J
DOI：
10.1002/art.41567
发表时间：
2021-03
期刊：
Arthritis & rheumatology (Hoboken, N.J.)
影响因子：
--
作者：
Gianfrancesco MA;Leykina LA;Izadi Z;Taylor T;Sparks JA;Harrison C;Trupin L;Rush S;Schmajuk G;Katz P;Jacobsohn L;Hsu TY;D'Silva KM;Serling-Boyd N;Wallwork R;Todd DJ;Bhana S;Costello W;Grainger R;Hausmann JS;Liew JW;Sirotich E;Sufka P;Wallace ZS;Machado PM;Robinson PC;Yazdany J;COVID-19 Global Rheumatology Alliance
通讯作者：
COVID-19 Global Rheumatology Alliance